VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
VERO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
VEROVenus Concept Inc.
$0.27$498989
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

VERO logoVenus Concept Inc.(VERO)Earnings, Financials & Key Ratios

VERO•NASDAQ
$0.27
Price updated Jun 20, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryAesthetics, dermatology, and wound care
AboutVenus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.Show more
  • Revenue$65M-15.1%
  • EBITDA-$23M+3.7%
  • Net Income-$47M-26.2%
  • EPS (Diluted)-66.28-869.0%
  • Gross Margin68.34%
  • EBITDA Margin-35.93%-13.4%
  • Operating Margin-41.93%-13.1%
  • Net Margin-72.49%-48.6%
  • ROE-1655.95%

VERO Price & Volume

Venus Concept Inc. (VERO) stock price & volume — 10-year historical chart

Loading chart...

Persistent Revenue Contraction Signals Structural Liquidity Crisis

Investment Thesis • Updated 2025Q3

VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Imminent liquidity crisis

Key Thesis Takeaways

  • Venus Concept faces a severe fundamental deterioration characterized by consistent top-line erosion and an inability to scale its operating infrastructure, as evidenced by a -68.9% operating margin in 2025Q3.
  • The company's reliance on debt financing, now reflected in a 10.42 debt-to-equity ratio, combined with a dwindling cash position of $5.9 million, suggests an imminent risk of insolvency.
  • Investors should remain cautious as the firm's accumulated deficit of $355.5 million and persistent negative free cash flow indicate that the current business model lacks the necessary capital efficiency to achieve long-term viability.

Verdict Logic

the company's precarious liquidity position, underscored by a current ratio of 0.90 and a $355.5 million accumulated deficit, suggests a high probability of further equity dilution or potential insolvency.

VERO Growth Metrics

Venus Concept Inc. (VERO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-10.1%
3 Years-15.01%
TTM-12.39%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-8.91%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-209.73%

Return on Capital

10 Years-71.94%
5 Years-37.54%
3 Years-41.93%
Last Year-54.16%

Peers Comparison

Key metrics vs top competitors for Venus Concept Inc. (VERO)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
VERO logoVEROVenus Concept Inc.Current
$0.27$498.99K-0.00-15.09%-72.49%-1655.95%—
INMD logoINMDInMode Ltd.
$14.54$921.24M10.17-6.16%23.27%13.28%—
SSKN logoSSKNSTRATA Skin Sciences, Inc.
$0.12$705.41K-0.09-8.54%-21.13%-360.33%—
LASE logoLASELaser Photonics Corporation
$1.30$22.27M-1.27131.96%-268.71%-4407.08%—
HIMS logoHIMSHims & Hers Health, Inc.
$36.17$7.94B70.9259%-0.56%-2.48%—
SKIN logoSKINThe Beauty Health Company
$1.11$143.86M-6.94-10.02%-2.03%-9.41%—

Compare VERO vs Peers

Venus Concept Inc. (VERO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs INMD

Most directly comparable listed peer for VERO.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare VERO against a more recognizable public peer.

Peer Set

Compare Top 5

vs INMD, SSKN, LASE, HIMS

Get notified when VERO posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

VERO Frequently Asked Questions

Venus Concept Inc. (VERO) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Venus Concept Inc.'s revenue?

Venus Concept Inc. (VERO) reported $58.9M in revenue for fiscal year 2024. This represents a 242% increase from $17.2M in 2015.

How fast is Venus Concept Inc. growing?

Venus Concept Inc. (VERO) saw revenue decline by 15.1% over the past year.

Is VERO profitable?

Venus Concept Inc. (VERO) reported a net loss of $54.6M for fiscal year 2024.

Dividend & Returns
What is VERO's return on equity?

Venus Concept Inc. (VERO) has a return on equity (ROE) of -1656.0%. Negative ROE indicates the company is unprofitable.

What is Venus Concept Inc.'s free cash flow?

Venus Concept Inc. (VERO) had negative free cash flow of $20.7M in fiscal year 2024, likely due to heavy capital investments.

What if you invested $1,000 in VERO back in 2015?

Total return calculator · dividends reinvested · 11+ years of data

See returns →